Discovery of promising cholinesterase inhibitors for Alzheimer's disease treatment through DFT, docking, and molecular dynamics studies of eugenol derivatives
Cholinesterase enzymes are promising drug targets for the symptomatic treatment of
Alzheimer's disease. Indeed, the activity inhibition of these acetylcholine‐degrading …
Alzheimer's disease. Indeed, the activity inhibition of these acetylcholine‐degrading …
Discovery of promising cholinesterase inhibitors for Alzheimer's disease treatment through DFT, docking, and molecular dynamics studies of eugenol derivatives.
H Nour, A Abdou, S Belaidi, JE Jamal… - Journal of the …, 2022 - search.ebscohost.com
Cholinesterase enzymes are promising drug targets for the symptomatic treatment of
Alzheimer's disease. Indeed, the activity inhibition of these acetylcholine‐degrading …
Alzheimer's disease. Indeed, the activity inhibition of these acetylcholine‐degrading …